ReviewSkeletal radiology2026
Fat-containing soft-tissue tumors: Imaging findings and pathologic correlation.
Review in Skeletal radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fat-containing soft-tissue tumors encompass a broad spectrum of entities, ranging from indolent lipomas to aggressive liposarcomas, many of which share overlapping MRI features that pose diagnostic challenges even for experienced radiologists. In this review, we provide a focused, evidence-based synthesis of the current literature to outline a practical framework for the imaging evaluation of adipocytic soft-tissue lesions. Key MRI features that aid in distinguishing benign from intermediate and malignant tumors are discussed, with emphasis on imaging-pathology correlation and common diagnostic pitfalls. While conventional MRI criteria, such as lesion size, depth, septal thickness, and nodularity, remain central to risk stratification, we also review the complementary role of contrast-enhanced MRI and molecular testing, including MDM2 amplification and FUS::DDIT3 fusion analysis, particularly in indeterminate cases. Emerging tools, such as radiomics and artificial intelligence-based approaches, are briefly addressed as evolving adjuncts. By integrating classical imaging principles with contemporary classification frameworks, this article aims to serve as a comprehensive and clinically relevant reference for radiologists involved in the assessment and management of fat-containing soft-tissue tumors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.